4D Molecular Therapeutics Inc Earnings

The next earnings date for 4D Molecular Therapeutics Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of 4D Molecular Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-1.01

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

4D Molecular Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/07/2025	---	$0	100.00%
05/07/2025	Before Market	$-0.86	0.24%
02/26/2025	Before Market	$-0.90	-7.41%
11/07/2024	After Market	$-0.79	-12.86%
08/08/2024	After Market	$-0.63	10.00%
05/09/2024	After Market	$-0.66	10.81%
02/29/2024	After Market	$-0.75	-1.35%
11/09/2023	After Market	$-0.24	59.32%
08/09/2023	After Market	$-0.77	4.94%
05/10/2023	After Market	$-0.88	1.12%
03/15/2023	After Market	$-0.84	-6.33%
11/08/2022	After Market	$-0.79	13.19%
08/11/2022	After Market	$-0.87	-2.35%
05/12/2022	After Market	$-0.82	-1.23%
03/28/2022	After Market	$-0.85	1.16%
11/10/2021	After Market	$-0.82	-2.50%
08/12/2021	After Market	$-0.28	58.82%
05/13/2021	After Market	$-0.61	44.55%
03/25/2021	After Market	$-2.36	-257.58%
12/16/2020	After Market	$-3.07	---
12/31/2019	---	$-3.12	---
09/30/2019	---	$-3.14	---
06/30/2019	---	$-1.61	---
03/31/2019	---	$-1.61	---
12/31/2018	---	$-0.43	---
09/30/2018	---	$-0.43	---
06/30/2018	---	$-0.52	---
03/31/2018	---	$-0.52	---

More About 4D Molecular Therapeutics Inc

Website

https://www.4dmoleculartherapeutics.com

Country

USA

Full Time Employees

227

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.

“4D Molecular Therapeutics Inc Earnings” Can Refer to the 4D Molecular Therapeutics Inc Earnings Date

Some people say “4D Molecular Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my 4D Molecular Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning 4D Molecular Therapeutics Inc Stock on the Earnings Date

If you own 4D Molecular Therapeutics Inc stock (FDMT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for 4D Molecular Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading 4D Molecular Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More 4D Molecular Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about 4D Molecular Therapeutics Inc earnings or anything else related to the stock market.